Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study

Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice

(2012) D. H. Nam et al.   ENDOCRINOLOGY

Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality

(2012) Mark Hamer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity

(2012) E. Heyman et al.   Obesity Reviews

The role of the endocannabinoid system in the neuroendocrine regulation of energy balance

(2011) Francisco Javier Bermudez-Silva et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cholecystokinin Exerts an Effect via the Endocannabinoid System to Inhibit GABAergic Transmission in Midbrain Periaqueductal Gray

(2011) Vanessa A Mitchell et al.   NEUROPSYCHOPHARMACOLOGY

Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle

(2010) K. A. Lindborg et al.   DIABETES OBESITY & METABOLISM

Characterizing the profile of obese patients who are metabolically healthy

(2010) V Primeau et al.   INTERNATIONAL JOURNAL OF OBESITY

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients

(2010) Giovanni Annuzzi et al.   Lipids in Health and Disease

The multiple functions of the endocannabinoid system: a focus on the regulation of food intake

(2010) Eduardo Tibiriça   Diabetology & Metabolic Syndrome

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases

(2009) Sivaram Pillarisetti et al.   DRUG DISCOVERY TODAY

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects

(2009) Vincenzo Di Marzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Resistance Training Does Not Contribute to Improving the Metabolic Profile after a 6-Month Weight Loss Program in Overweight and Obese Postmenopausal Women

(2009) Martin Brochu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Endocannabinoid System: Potential for Reducing Cardiometabolic Risk

(2009) Henry N. Ginsberg et al.   Obesity

Identification and Characterization of Metabolically Benign Obesity in Humans

(2008) Norbert Stefan   ARCHIVES OF INTERNAL MEDICINE

Endocannabinoid system overactivity and the metabolic syndrome: Prospects for treatment

(2008) Jennifer M. Perkins et al.   Current Diabetes Reports

The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids

(2008) T. M. D'Eon et al.   DIABETES

The endocannabinoid system in obesity and type 2 diabetes

(2008) V. Di Marzo   DIABETOLOGIA

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

(2008) V. Di Marzo et al.   DIABETOLOGIA

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

Contribution of the Lean Body Mass to Insulin Resistance in Postmenopausal Women With Visceral Obesity: A Monet Study

(2008) Martin Brochu et al.   Obesity

Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β-cells

(2007) I Matias et al.   BRITISH JOURNAL OF PHARMACOLOGY